1. Are, C., Rajaram, S., Are, M., Raj, H., Anderson, B. O., Chaluvarya Swamy, R., Vijayakumar, M., Song, T., Pandey, M., Edney, J. A., and Cazap, E. L. (2013) A review of global cancer burden: trends, challenges, strategies, and a role for surgeons, J. Surg. Oncol., 107, 221–226.
2. Kulkarni, P., Shiraishi, T., Rajagopalan, K., Kim, R., Mooney, S. M., and Getzenberg, R. H. (2012) Cancer/testis antigens and urological malignancies, Nat. Rev. Urol., 9, 386–396.
3. Ries, L. A. G., Horner, M.-J., and Young, J. L. (2007) Introduction, in SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988–2001, Patient and Tumor Characteristics (Ries, L. A. G., Young, J. L., Keel, G. E., Eisner, M. P., Lin, Y. D., and Horner, M.- J., eds.) National Cancer Institute, SEER Program, NIH, Bethesda, pp. 1–6.
4. Graziano, D. F., and Finn, O. J. (2005) Tumor antigens and tumor antigen discovery, Cancer Treat. Res., 123, 89–111.
5. Aly, H. A. (2012) Cancer therapy and vaccination, J. Immunol. Methods, 382, 1–23.